11Preoperative assessment of myometrial invasion of endometrial cancer by magnetic resonance imaging and intrauterine ultrasonography with a high-frequency probe : Preliminary study
Tsuda H, Murata K, Kawabata M, Yamamoto K
1997Ultrasound Med Biol 16545-548
12Clinical predictors in the natural history of uterine fibroids : Preliminary study
Tsuda H, Kawabata M, Nakamoto O, Yamamoto K
1998Ultrasound Med Biol 1717-20
13The p16-Cyclin D1/CDK4/pRb pathway and clinical outcome in epithelial ovarian cancer
Kusume T, Tsuda H, Kawabata M, Inoue T, Umesaki N, Suzuki T, Yamamoto K
1999Clin Cancer Res 54152-4157
14The role of p16-cyclinD/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma
Tsuda H, Yamamoto K, Inoue T, Uchiyama I, Umesaki N
2000Br J Cancer 82675-682
15Excellent results of radiotherapy for neuroendocrine carcinoma of the uterine cervix
Nakata S, Yamamoto K, Kobayashi Y, Maeda K, Tsuda H, Ishiko O
2001Oncol Rep 4777-779
16Combined analysis of p53 and RB pathways in epithelial ovarian cancer
Hashiguchi Y, Tsuda H, Yamamoto K, Inoue T, Ishiko O, Ogita S
2001Human Pathol 32988-996
17Phase I-II study of neoadjuvant chemoradiotherapy followed by radical surgery in locally advanced cervical cancer
Tsuda H, Tanaka M, Manabe T, Nakata S, Ishiko O, Yamamoto K
2001ANTI-CANCER DRUGS 12853-858
18Relationship between p53 pathway and estrogen receptor status in endometrioid-type endometrial cancer
Maeda K, Tsuda H, Hashiguchi Y, Yamamoto K, Inoue T, Ishiko O, Ogita S
2001Human Pathol 33386-391
19Malignant rhabdoid tumour of the uterine cervix
Tsuda H, Maeda K, Hashiguchi Y, Inoue T, Kobayashi Y, Umesaki N, Yamamoto K
2001Br J Obstet Gynaecol 108120-123
20The CA125 regression rate to predict overall survival differ between paclitaxel-containing regimen and nonpaclitaxel regimen in patients with advanced ovarian cancer
Tsuda H, Hashiguchi Y, Nakata S, Deguchi M, Yamamoto K
